rs397517252

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_014391.3(ANKRD1):​c.652-10A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,603,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

ANKRD1
NM_014391.3 intron

Scores

2
Splicing: ADA: 0.00001418
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.940

Publications

0 publications found
Variant links:
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]
ANKRD1 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 10-90915890-T-A is Benign according to our data. Variant chr10-90915890-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 45636.
BS2
High AC in GnomAd4 at 32 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014391.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANKRD1
NM_014391.3
MANE Select
c.652-10A>T
intron
N/ANP_055206.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANKRD1
ENST00000371697.4
TSL:1 MANE Select
c.652-10A>T
intron
N/AENSP00000360762.3

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
32
AN:
143450
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.000667
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000207
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000297
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000153
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000216
AC:
52
AN:
240236
AF XY:
0.000146
show subpopulations
Gnomad AFR exome
AF:
0.000674
Gnomad AMR exome
AF:
0.000296
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000863
Gnomad NFE exome
AF:
0.0000927
Gnomad OTH exome
AF:
0.000677
GnomAD4 exome
AF:
0.000110
AC:
161
AN:
1460244
Hom.:
0
Cov.:
32
AF XY:
0.000103
AC XY:
75
AN XY:
726440
show subpopulations
African (AFR)
AF:
0.000628
AC:
21
AN:
33434
American (AMR)
AF:
0.000403
AC:
18
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39626
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86140
European-Finnish (FIN)
AF:
0.000693
AC:
37
AN:
53366
Middle Eastern (MID)
AF:
0.000409
AC:
2
AN:
4884
European-Non Finnish (NFE)
AF:
0.0000675
AC:
75
AN:
1111680
Other (OTH)
AF:
0.000133
AC:
8
AN:
60282
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000223
AC:
32
AN:
143550
Hom.:
0
Cov.:
29
AF XY:
0.000200
AC XY:
14
AN XY:
69986
show subpopulations
African (AFR)
AF:
0.000666
AC:
25
AN:
37564
American (AMR)
AF:
0.000206
AC:
3
AN:
14540
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3404
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4922
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4468
European-Finnish (FIN)
AF:
0.000297
AC:
3
AN:
10090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.0000153
AC:
1
AN:
65352
Other (OTH)
AF:
0.00
AC:
0
AN:
2018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000356
Hom.:
0
Bravo
AF:
0.000219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Nov 19, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The 652-10A>T varia nt in ANKRD1 has not been reported in the literature nor previously identified b y our laboratory. This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing and this variant is closer to the co nsensus sequence than the wild-type, though this information is not predictive e nough to rule out pathogenicity. In summary, this variant is more likely benign based on its location and predicted impact on splicing, but additional studies a re needed to fully assess its clinical significance.

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Congenital total pulmonary venous return anomaly Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:1
Nov 03, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANKRD1-related dilated cardiomyopathy Benign:1
Nov 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ANKRD1-related disorder Benign:1
Jul 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.8
DANN
Benign
0.63
PhyloP100
-0.94

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397517252; hg19: chr10-92675647; API